Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 373 entries
View as:

Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00606359 Org: User:
Start: 11/30/07 End: 06/30/08 Due: 06/30/09

Database Surveillance Safety Study of PENTACEL® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00804284 Org: User:
Start: 09/30/08 End: 01/31/15 Due: 01/31/16

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01608815 Org: User:
Start: 05/31/12 End: 12/31/12 Due: 12/31/13

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00875524 Org: User:
Start: 03/31/09 End: 12/31/14 Due: 12/31/15

A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants

Phase: N/A Priority: Normal
NCT ID: NCT01177722 Org: User:
Start: 08/31/10 End: 12/31/11 Due: 12/31/12

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00928785 Org: User:
Start: 07/31/09 End: 12/31/09 Due: 12/31/10

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00703651 Org: User:
Start: 09/30/03 End: 07/31/06 Due: 07/31/07

Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00948272 Org: User:
Start: 07/31/09 End: 08/31/11 Due: 08/31/12

Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

Phase: N/A Priority: Normal
NCT ID: NCT02633787 Org: User:
Start: 12/31/15 End: 03/31/16 Due: 03/31/17

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT06134648 Org: User:
Start: 11/01/23 End: 03/10/26 Due: 03/10/27

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00258908 Org: User:
Start: 11/30/05 End: 08/31/06 Due: 08/31/07

Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®

Phase: N/A Priority: Normal
NCT ID: NCT00362427 Org: User:
Start: 08/31/06 End: 03/31/09 Due: 03/31/10

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Phase: N/A Priority: Normal
NCT ID: NCT03869866 Org: User:
Start: 04/09/19 End: 03/18/22 Due: 03/18/23

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Phase: N/A Priority: Normal
NCT ID: NCT02428491 Org: User:
Start: 04/20/15 End: 01/11/17 Due: 01/11/18

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

Phase: N/A Priority: Normal
NCT ID: NCT02623725 Org: User:
Start: 04/14/16 End: 10/28/18 Due: 10/28/19

Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02011763 Org: User:
Start: 12/31/13 End: 08/31/15 Due: 08/31/16

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04798027 Org: User:
Start: 03/12/21 End: 06/27/22 Due: 06/27/23

Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®

Phase: N/A Priority: Normal
NCT ID: NCT00355654 Org: User:
Start: 09/30/06 End: 07/31/08 Due: 07/31/09

Safety of Imovax Polio in Chinese Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00258843 Org: User:
Start: 11/30/05 End: 04/30/06 Due: 04/30/07

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00772070 Org: User:
Start: 03/31/03 End: 05/31/04 Due: 05/31/05

Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States

Phase: N/A Priority: Normal
NCT ID: NCT05040802 Org: User:
Start: 06/02/21 End: 10/04/21 Due: 10/04/22

BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)

Phase: N/A Priority: Normal
NCT ID: NCT06325332 Org: User:
Start: 04/01/24 End: 06/30/25 Due: 06/30/26

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01339312 Org: User:
Start: 04/30/11 End: 09/30/12 Due: 09/30/13

Immunogenicity Study of the Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00258934 Org: User:
Start: 09/30/05 End: 09/30/08 Due: 09/30/09

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04904549 Org: User:
Start: 08/20/20 End: 08/31/24 Due: 08/31/25